Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.

about

Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.

P2860

Q49276761-B97F0B86-93B6-4263-9E28-8D57DE4EF86C

P2860

Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.

Item

http://www.wikidata.org/entity/Q51280183

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Specific autoantibodies in der ...... fy different clinical subsets.

@en

Specific autoantibodies in der ...... fy different clinical subsets.

@nl

type

Item

label

Specific autoantibodies in der ...... fy different clinical subsets.

@en

Specific autoantibodies in der ...... fy different clinical subsets.

@nl

prefLabel

Specific autoantibodies in der ...... fy different clinical subsets.

@en

Specific autoantibodies in der ...... fy different clinical subsets.

@nl

P1476

Specific autoantibodies in der ...... fy different clinical subsets.

@en

P2093

Andrea Clapasson

http://www.w3.org/2001/XMLSchema#string

Aurora Parodi

http://www.w3.org/2001/XMLSchema#string

Emanuele Cozzani

http://www.w3.org/2001/XMLSchema#string

Giampaola Pesce

http://www.w3.org/2001/XMLSchema#string

Giulia Merlo

http://www.w3.org/2001/XMLSchema#string

Luigi Sanna

http://www.w3.org/2001/XMLSchema#string

Marcello Bagnasco

http://www.w3.org/2001/XMLSchema#string

Martina Burlando

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of inflammatory myopathy: emerging therapies and therapeutic targets

Signal recognition particle contains a 7S RNA essential for protein translocation across the endoplasmic reticulum

Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis.

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.

Polymyositis and dermatomyositis (second of two parts).

Polymyositis and dermatomyositis (first of two parts).

Morbidity and mortality in adult polymyositis and dermatomyositis.

Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis.

A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy

P2888

s00403-016-1704-1

P304

87-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00403-016-1704-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

309

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27928683

http://www.w3.org/2001/XMLSchema#string

P921

dermatomyositis

autoantibody

Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.

about

P2860

P2860

Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921